This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jyothirmayi, G. N. Articles by Reddi, A. S. Search for Related Content PubMed PubMed Citation Articles by Jyothirmayi, G. N. Articles by Reddi, A. S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB DILTIAZEM

Hypertension, Vol 21, 795-802, Copyright © 1993 by American Heart Association

ARTICLES

Effect of diltiazem on glomerular heparan sulfate and albuminuria in diabetic rats

GN Jyothirmayi and AS Reddi
Department of Medicine, UMDNJ-New Jersey Medical School, Newark 07103.

Calcium entry blockers, particularly diltiazem, have been shown to lower not only systemic blood pressure but also improve proteinuria in non-insulin-dependent diabetic patients. The presence of proteinuria is attributed to the loss of glomerular heparan sulfate, which confers a negative charge on the basement membrane. In the present study, we evaluated the efficacy of diltiazem in lowering blood pressure and proteinuria in diabetic rats and also examined the possibility that diltiazem prevents proteinuria through glomerular preservation of heparan sulfate. Diabetes was induced in male Wistar rats by streptozotocin (60 mg/kg). One group of diabetic rats was treated with diltiazem (25 mg/L) in drinking water for 20 weeks. Another group of diabetic rats and a group of nondiabetic rats were given tap water only. Systolic blood pressure was measured at 4, 8, 12, and 20 weeks. Urinary excretion of albumin was done at 4, 8, 12, 16, and 20 weeks. At the end of 20 weeks, all rats were killed, kidneys were removed, and glomeruli were isolated. Total glycosaminoglycan and heparan sulfate synthesis were determined by incubating glomeruli in the presence of [35S]sulfate. Diltiazem lowered blood pressure significantly in diabetic rats at 8, 12, and 20 weeks. Diabetic glomeruli synthesized less total glycosaminoglycan and heparan sulfate than glomeruli from normal rats. Characterization of heparan sulfate by ion-exchange chromatography showed that the fraction eluted with 1 M NaCl was significantly lower and the fraction eluted with 1.25 M NaCl significantly higher in diabetic than in normal rats. Diltiazem therapy returned not only glomerular synthesis but also various fractions of heparan sulfate to normal.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. S. Reddi, V. R. Nimmagadda, A. Lefkowitz, H.-R. Kuo, and J. S. Bollineni Effect of Antihypertensive Therapy on Renal Injury in Type 2 Diabetic Rats With Hypertension Hypertension, August 1, 2000; 36(2): 233 - 238. [Abstract] [Full Text] [PDF]

				B. Nielsen and A. Flyvbjerg Calcium channel blockers - the effect on renal changes in clinical and experimental diabetes: an overview Nephrol. Dial. Transplant., May 1, 2000; 15(5): 581 - 585. [Full Text] [PDF]

				G. N. Jyothirmayi, I. Alluru, and A. S. Reddi Doxazosin Prevents Proteinuria and Glomerular Loss of Heparan Sulfate in Diabetic Rats Hypertension, May 1, 1996; 27(5): 1108 - 1114. [Abstract] [Full Text]